- Home
- CMCM vs OKYO Comparison
CMCM vs OKYO Comparison
Compare CMCM & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCM
- OKYO
- Stock Information
- Founded
- CMCM 2009
- OKYO 2007
- Country
- CMCM China
- OKYO United Kingdom
- Employees
- CMCM N/A
- OKYO N/A
- Industry
- CMCM Computer Software: Prepackaged Software
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CMCM Technology
- OKYO Health Care
- Exchange
- CMCM Nasdaq
- OKYO Nasdaq
- Market Cap
- CMCM 115.1M
- OKYO 95.3M
- IPO Year
- CMCM 2014
- OKYO 2022
- Fundamental
- Price
- CMCM $5.81
- OKYO $2.37
- Analyst Decision
- CMCM
- OKYO Strong Buy
- Analyst Count
- CMCM 0
- OKYO 1
- Target Price
- CMCM N/A
- OKYO $7.00
- AVG Volume (30 Days)
- CMCM 32.8K
- OKYO 188.6K
- Earning Date
- CMCM 09-12-2025
- OKYO 07-18-2025
- Dividend Yield
- CMCM N/A
- OKYO N/A
- EPS Growth
- CMCM N/A
- OKYO N/A
- EPS
- CMCM N/A
- OKYO N/A
- Revenue
- CMCM $120,663,543.00
- OKYO N/A
- Revenue This Year
- CMCM $14.27
- OKYO N/A
- Revenue Next Year
- CMCM $39.26
- OKYO N/A
- P/E Ratio
- CMCM N/A
- OKYO N/A
- Revenue Growth
- CMCM 27.02
- OKYO N/A
- 52 Week Low
- CMCM $3.28
- OKYO $0.85
- 52 Week High
- CMCM $6.77
- OKYO $3.35
- Technical
- Relative Strength Index (RSI)
- CMCM 62.87
- OKYO 40.19
- Support Level
- CMCM $5.25
- OKYO $2.20
- Resistance Level
- CMCM $6.62
- OKYO $2.51
- Average True Range (ATR)
- CMCM 0.32
- OKYO 0.25
- MACD
- CMCM 0.07
- OKYO -0.09
- Stochastic Oscillator
- CMCM 84.39
- OKYO 14.80
About CMCM Cheetah Mobile Inc. each representing fifty (50)
Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.